These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31387112)

  • 21. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY.
    Mohabati D; Schellevis RL; van Dijk EHC; Fauser S; den Hollander AI; Hoyng CB; De Jong EK; Yzer S; Boon CJF
    Retina; 2020 Sep; 40(9):1734-1741. PubMed ID: 31815877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
    Xu Y; Su Y; Li L; Qi H; Zheng H; Chen C
    Ophthalmologica; 2017; 237(3):167-172. PubMed ID: 28171871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.
    Breukink MB; Downes SM; Querques G; van Dijk EHC; den Hollander AI; Blanco-Garavito R; Keunen JEE; Souied EH; MacLaren RE; Hoyng CB; Fauser S; Boon CJF
    Trials; 2015 Sep; 16():419. PubMed ID: 26390920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome.
    van Dijk EH; Dijkman G; Biermasz NR; van Haalen FM; Pereira AM; Boon CJ
    Eur J Ophthalmol; 2016 Aug; 26(5):442-8. PubMed ID: 27135093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy.
    Scholz P; Ersoy L; Boon CJ; Fauser S
    Ophthalmologica; 2015; 234(4):189-94. PubMed ID: 26406874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
    Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Leys E; Tuttle S; Rasquin F; Neu F; Postelmans L
    J Fr Ophtalmol; 2015 Oct; 38(8):709-16. PubMed ID: 26345542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annular Lesions and Catenary Forms in Chronic Central Serous Chorioretinopathy.
    Dansingani KK; Balaratnasingam C; Mrejen S; Inoue M; Freund KB; Klancnik JM; Yannuzzi LA
    Am J Ophthalmol; 2016 Jun; 166():60-67. PubMed ID: 27021439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bilateral abnormalities in central serous chorioretinopathy seen in optical coherence tomography, ultra-widefield fluorescein angiography and microperimetry--case report].
    Tylus M; Święch-Zubilewicz A; Dolar-Szczasny J; Mackiewicz J
    Klin Oczna; 2015; 117(3):173-6. PubMed ID: 26999941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic central serous chorioretinopathy (cCSC): differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD)].
    Inhoffen W; Ziemssen F; Bartz-Schmidt KU
    Klin Monbl Augenheilkd; 2012 Sep; 229(9):889-96. PubMed ID: 22930236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
    Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
    Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Scholz P; Altay L; Fauser S
    Eye (Lond); 2016 Oct; 30(10):1371-1377. PubMed ID: 27391938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
    Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics.
    Bae K; Nam SW; Kang SW; Kim ES; Yu SY; Kim KT; Kim SJ
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):279-288. PubMed ID: 30564905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
    Lee H; Lee J; Chung H; Kim HC
    Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
    Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
    Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.